Display options
Cite
Callaghan BC, Burke JF, Rodgers A, et al. Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts?. Neurol Clin Pract. 2013;3(5):421-430doi: 10.1212/CPJ.0b013e3182a78fb1.
Callaghan, B. C., Burke, J. F., Rodgers, A., McCammon, R., Langa, K. M., Feldman, E. L., & Kerber, K. A. (2013). Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts?. Neurology. Clinical practice, 3(5), 421-430. https://doi.org/10.1212/CPJ.0b013e3182a78fb1
Callaghan, Brian C, et al. "Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts?." Neurology. Clinical practice vol. 3,5 (2013): 421-430. doi: https://doi.org/10.1212/CPJ.0b013e3182a78fb1
Callaghan BC, Burke JF, Rodgers A, McCammon R, Langa KM, Feldman EL, Kerber KA. Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts?. Neurol Clin Pract. 2013 Oct;3(5):421-430. doi: 10.1212/CPJ.0b013e3182a78fb1. PMID: 24175158; PMCID: PMC3806930.
Copy Download .nbib Format: NLM
Share it on

Neurol Clin Pract. 2013 Oct;3(5):421-430. doi: 10.1212/CPJ.0b013e3182a78fb1.

Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts?.

Neurology. Clinical practice

Brian C Callaghan, James F Burke, Ann Rodgers, Ryan McCammon, Kenneth M Langa, Eva L Feldman, Kevin A Kerber

Affiliations

  1. University of Michigan (BC, JB, AR, RM, KML, EF, KK); VA Center for Clinical Management Research (JB, KML); and Institute for Social Research (KML), Ann Arbor.

PMID: 24175158 PMCID: PMC3806930 DOI: 10.1212/CPJ.0b013e3182a78fb1

Abstract

To optimize care in the evaluation of peripheral neuropathy, we sought to define which tests drive expenditures and the role of the provider type. We investigated test utilization and expenditures by provider type in those with incident neuropathy in a nationally representative elderly, Medicare population. Multivariable logistic regression was used to determine predictors of MRI and electrodiagnostic utilization. MRIs of the neuroaxis and electrodiagnostic tests accounted for 88% of total expenditures. Mean and aggregate diagnostic expenditures were higher in those who saw a neurologist. Patients who saw a neurologist were more likely to receive an MRI and an electrodiagnostic test. MRIs and electrodiagnostic tests are the main contributors to expenditures in the evaluation of peripheral neuropathy, and should be the focus of future efficiency efforts.

References

  1. Neurology. 1981 Nov;31(11):1480-3 - PubMed
  2. Arch Neurol. 2003 Sep;60(9):1296-301 - PubMed
  3. Arch Intern Med. 2012 Jan 23;172(2):127-32 - PubMed
  4. Neurology. 1993 Jun;43(6):1115-20 - PubMed
  5. Arch Intern Med. 2011 Nov 14;171(20):1856-8 - PubMed
  6. Neurology. 2009 Jan 13;72(2):185-92 - PubMed
  7. Neurology. 1991 Aug;41(8):1315-7 - PubMed
  8. Arch Neurol. 2012 Mar;69(3):339-45 - PubMed
  9. Diabetes Care. 2004 Jul;27(7):1591-7 - PubMed
  10. Health Serv Res. 2004 Dec;39(6 Pt 1):1839-57 - PubMed
  11. JAMA. 2012 May 2;307(17):1801-2 - PubMed

Publication Types

Grant support